60 First-line Nivolumab/Ipilimumab in patients with unresectable malignant pleural Mesothelioma (MPM): West of Scotland experience

We present our local experience of patients with MPM treated with Ipilimumab plus Nivolumab.

Source: Lung Cancer - April 1, 2024 Category: Cancer & Oncology Authors: Aitzaz Qaisar, Mark White, Nicola Steele Tags: Mesothelioma Source Type: research